3 alpha-Hydroxy-3 beta-trifluoromethyl-5 alpha-pregnan-20-one (Co 2- 1970): a partial agonist at the neuroactive steroid site of the gamma- aminobutyric acidA receptor

JE Hawkinson, JA Drewe, CL Kimbrough, JS Chen, DJ Hogenkamp, NC Lan, KW Gee, KZ Shen, ER Whittemore and RM Woodward

CoCensys, Inc., Irvine, California 92718, USA.

Neuroactive steroids bind to a unique site on the gamma-aminobutyric acidA (GABAA) receptor complex and allosterically modulate the binding of convulsant ([35S]t-butylbicyclophosphorothionate, [35S]TBPS), GABA ([3H]muscimol), and benzodiazepine ([3H]flunitrazepam) site ligands. In rat cortical membranes, 3 alpha-hydroxy-5 alpha-pregnan-20-one (3 alpha, 5 alpha-P) is a full agonist at the steroid site, inhibiting 96% of specific [35S]TBPS binding and enhancing [3H]flunitrazepam and [3H]muscimol binding 95% and 69% above control levels, respectively. In contrast, the synthetic steroid 3 alpha-hydroxy-3 beta-trifluoromethyl- 5 alpha-pregnan-20-one (Co 2-1970) has limited efficacy for modulating the binding of [35S]TBPS (44% inhibition), [3H]flunitrazepam (41% enhancement), and [3H]muscimol (< 10% enhancement). In competition experiments, Co 2-1970 (10 microM) reduced the apparent potency of 3 alpha, 5 alpha-P by 7-17-fold for modulating the binding of these radioligands in rat cortical membranes, suggesting that it has partial agonist properties. Because cortical membranes contain a heterogeneous population of receptors, Co 2-1970 was examined in recombinant GABAA receptors stably expressed in human embryonic kidney 293 cells. Co 2- 1970 inhibited [35S]TBPS binding with limited efficacy (39-65% inhibition) in the five receptor combinations examined and, at 10 microM, reduced the apparent potency of 3 alpha, 5 alpha-P 57-fold for inhibiting [35S]TBPS binding to alpha 1 beta 1 gamma 2L receptors. To verify these findings functionally, the effects of 3 alpha, 5 alpha-P and Co 2-1970 were examined electrophysiologically in Xenopus oo-cytes expressing alpha 1 beta 1 gamma 2L receptors. Co 2-1970 showed limited efficacy potentiation of GABA-evoked chloride currents relative to 3 alpha, 5 alpha-P (28% and 86% of the GABA maximum current, respectively). Moreover, Co 2-1970 produced a concentration-dependent antagonism of the 3 alpha, 5 alpha-P-induced potentiation that was associated with a reduction in the apparent affinity of 3 alpha, 5 alpha-P (11-fold at 10 microM Co 2-1970). Taken together, these data indicate that Co 2-1970 is a partial agonist at the neuroactive steroid site associated with GABAA receptors.

Volume 49, Issue 5, pp. 897-906, 05/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				R. F. Yoshimura, D. J. Hogenkamp, W. Y. Li, M. B. Tran, J. D. Belluzzi, E. R. Whittemore, F. M. Leslie, and K. W. Gee Negative Allosteric Modulation of Nicotinic Acetylcholine Receptors Blocks Nicotine Self-Administration in Rats J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 907 - 915. [Abstract] [Full Text] [PDF]

				H. J. Ng, E. R. Whittemore, M. B. Tran, D. J. Hogenkamp, R. S. Broide, T. B. Johnstone, L. Zheng, K. E. Stevens, and K. W. Gee Nootropic {alpha}7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators PNAS, May 8, 2007; 104(19): 8059 - 8064. [Abstract] [Full Text] [PDF]

				R. Darbandi-Tonkabon, B. D. Manion, W. R. Hastings, W. J. Craigen, G. Akk, J. R. Bracamontes, Y. He, T. V. Sheiko, J. H. Steinbach, S. J. Mennerick, et al. Neuroactive Steroid Interactions with Voltage-Dependent Anion Channels: Lack of Relationship to GABAA Receptor Modulation and Anesthesia J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 502 - 511. [Abstract] [Full Text] [PDF]

				R. Darbandi-Tonkabon, W. R. Hastings, C.-M. Zeng, G. Akk, B. D. Manion, J. R. Bracamontes, J. H. Steinbach, S. J. Mennerick, D. F. Covey, and A. S. Evers Photoaffinity Labeling with a Neuroactive Steroid Analogue. 6-AZI-PREGNANOLONE LABELS VOLTAGE-DEPENDENT ANION CHANNEL-1 IN RAT BRAIN J. Biol. Chem., April 4, 2003; 278(15): 13196 - 13206. [Abstract] [Full Text] [PDF]

				R.-Q. Huang, C. L. Bell-Horner, M. I. Dibas, D. F. Covey, J. A. Drewe, and G. H. Dillon Pentylenetetrazole-Induced Inhibition of Recombinant gamma -Aminobutyric Acid Type A (GABAA) Receptors: Mechanism and Site of Action J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 986 - 995. [Abstract] [Full Text]

				K. E. Vanover, S. Rosenzweig-Lipson, J. E. Hawkinson, N. C. Lan, J. D. Belluzzi, L. Stein, J. E. Barrett, P. L. Wood, and R. B. Carter Characterization of the Anxiolytic Properties of a Novel Neuroactive Steroid, Co 2-6749 (GMA-839; WAY-141839; 3alpha , 21-Dihydroxy-3beta -trifluoromethyl-19-nor-5beta -pregnan-20-one), a Selective Modulator of gamma -Aminobutyric AcidA Receptors J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 337 - 345. [Abstract] [Full Text]

				J. E. Hawkinson, M. Acosta-Burruel, K. C. Yang, D. J. Hogenkamp, J.-S. Chen, N. C. Lan, J. A. Drewe, E. R. Whittemore, R. M. Woodward, R. B. Carter, et al. Substituted 3beta -Phenylethynyl Derivatives of 3alpha -Hydroxy-5alpha -pregnan-20-one: Remarkably Potent Neuroactive Steroid Modulators of gamma -Aminobutyric AcidA Receptors J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 198 - 207. [Abstract] [Full Text]

				E. R. Whittemore, V. I. Ilyin, and R. M. Woodward Antagonism of N-Methyl-D-Aspartate Receptors by sigma  Site Ligands: Potency, Subtype-Selectivity and Mechanisms of Inhibition J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 326 - 338. [Abstract] [Full Text]

				B. G. Xue, E. R. Whittemore, C. H. Park, R. M. Woodward, N. C. Lan, and K. W. Gee J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1095 - 1101. [Abstract] [Full Text]